1 Hutchison Pharmaceuticals Announces Approval Of Cd73 Monoclonal Antibody Mupadolimab In Phase I/Ib Clinical Trial In China Feb 22, 2025
3 New Targeted Drug For Leukaemia Approved, 35% Of Patients' Cancer Cells Disappear Completely! Feb 06, 2025
4 Immune And Astrazeneca Launch Strategic Research Collaboration To Accelerate Drug Target Discovery Feb 02, 2025
5 New CAR-T Therapy CB-010, Granted Two FDA Designations And Three Patients Are Cancer-Free For Six Months! Jan 31, 2025
6 New Study Reveals Antibiotic Abuse For Sore Throats Pushes Up The Third Leading Cause Of Death Worldwide Jan 29, 2025
Read More Medical Pfizer's New Treatment Elranatamab Receives FDA Breakthrough Therapy Designation For Relapsed Or Refractory Multiple Myeloma May 12, 2025
Read More Disease What Are The Side Effects Of Radiotherapy For Prostate Cancer? What Should Patients With Prostate Cancer Be Aware Of? Apr 26, 2025
Read More Medical Significant Improvement In Survival For Pancreatic Cancer Patients! A first-Line NALIRIFOX Regimen To Look Forward To! May 03, 2025
Read More Hospital Dana-Farber Cancer Research, Teaching Affiliate, Harvard Medical School Apr 26, 2025
